We are live on ! Find out more
U

UBS Portfolio holdings

AUM $136B
1-Year Est. Return 16.36%
This Fund
S&P 500
This Quarter Est. Return
+1.89%
1 Year Est. Return
+16.36%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$113B
AUM Growth
+$5.56B
Cap. Flow
+$4.14B
Cap. Flow %
3.68%
Top 10 Hldgs %
14.26%
Holding
11,559
New
1,144
Increased
4,238
Reduced
4,557
Closed
1,117

Sector Composition

Rank Sector Weight
1 Energy 8.95%
2 Financials 7.03%
3 Technology 6.55%
4 Healthcare 6.54%
5 Industrials 5.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMRB
8351
DELISTED
American River Bankshares
AMRB
$16K ﹤0.01%
1,737
+1,441
+487% +$14.1K
AXAS
8352
CALL
DELISTED
Abraxas Petroleum Corp
AXAS
$16K ﹤0.01%
200
-315
-61% -$21.2K
BGG
8353
CALL
DELISTED
Briggs & Stratton Corp.
BGG
$16K ﹤0.01%
700
+200
+40% +$4.36K
ACHN
8354
CALL
DELISTED
Achillion Pharmaceuticals
ACHN
$16K ﹤0.01%
4,800
-39,300
-89% -$138K
UQM
8355
CALL
DELISTED
UQM Technologies, Inc.
UQM
$16K ﹤0.01%
6,200
+5,600
+933% +$11.9K
CMDT
8356
DELISTED
iShares Commodity Optimized Trust
CMDT
$16K ﹤0.01%
+300
New +$15.5K
CALD
8357
PUT
DELISTED
Callidus Software, Inc.
CALD
$16K ﹤0.01%
1,300
+900
+225% +$11.8K
CCUR
8358
PUT
DELISTED
CCUR Holdings, Inc. Common Stock
CCUR
$16K ﹤0.01%
+2,000
New +$16.7K
MACK
8359
CALL
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$16K ﹤0.01%
394
-381
-49% -$16.3K
WINT
8360
PUT
DELISTED
Windtree Therapeutics Inc
WINT
$16K ﹤0.01%
543
-778
-59% -$26.2K
VLTC
8361
DELISTED
Voltari Corporation
VLTC
$16K ﹤0.01%
4,500
+2,416
+116% +$9.19K
OSHC
8362
DELISTED
Ocean Shore Holding Co.
OSHC
$16K ﹤0.01%
1,095
+374
+52% +$5.23K
VMEM
8363
PUT
DELISTED
VIOLIN MEMORY, INC.
VMEM
$16K ﹤0.01%
+1,000
New +$16.2K
CSUN
8364
CALL
DELISTED
CHINA SUNERGY CO LTD ADS(CAYMAN ISLANDS)
CSUN
$16K ﹤0.01%
+3,800
New +$21.8K
MR
8365
CALL
DELISTED
MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A
MR
$16K ﹤0.01%
500
RBY
8366
CALL
DELISTED
RUBICON MENERALS CORP (F)
RBY
$16K ﹤0.01%
15,000
-1,000
-6% -$1.24K
ENVI
8367
DELISTED
ENVIVIO INC COM STK (DE)
ENVI
$16K ﹤0.01%
5,289
+4,219
+394% +$15K
EPAX
8368
DELISTED
Ambassadors Group Inc
EPAX
$16K ﹤0.01%
+4,146
New +$17.4K
BALT
8369
CALL
DELISTED
BALTIC TRADING LIMITED COMMON STOCK
BALT
$16K ﹤0.01%
2,600
+2,300
+767% +$14.6K
TLR
8370
DELISTED
TIMBERLINE RES COR COM NEW (DE)
TLR
$16K ﹤0.01%
8,708
+7,953
+1,053% +$16.2K
CHC
8371
DELISTED
CHINA HYDROELECTRIC CORP SPONSORED ADR RPSTG 3 ORD SHS
CHC
$16K ﹤0.01%
4,784
-1,507
-24% -$4.97K
SYE
8372
DELISTED
SPDR MFS Systematic Core Equity ETF of SSgA Active Trust
SYE
$16K ﹤0.01%
+300
New +$15K
OSIR
8373
CALL
DELISTED
Osiris Therapeutics, Inc. Common Stock
OSIR
$16K ﹤0.01%
1,200
+100
+9% +$1.56K
FOIL
8374
DELISTED
iPath Pure Beta Aluminum ETN
FOIL
$16K ﹤0.01%
600
+246
+69% +$6.77K
LNCO
8375
PUT
DELISTED
LINNCO LLC COM SHS REPSTG LTD LIABILITY
LNCO
$16K ﹤0.01%
600
-2,400
-80% -$73.1K

Similar funds

UBS's Q1 2014 Portfolio in Review

As of Q1 2014, UBS held 11,559 positions worth $113B, up 5.2% from $107B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

UBS deployed $4.14B of net new capital in Q1 2014, opening 1,144 new positions and adding to 4,238 existing holdings. Its largest new stake was iShares MSCI USA Quality Factor ETF: 336,642 shares worth $19M.

By sector, the portfolio is most concentrated in Energy at 9% of assets, up from 8.5% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Herc Holdings, an estimated $419M trimmed.

  • UBS's largest Q1 2014 buy was iShares MSCI USA Quality Factor ETF: 336,642 shares worth $19M.
  • UBS added most to State Street SPDR S&P 500 ETF Trust in Q1 2014, an estimated $1.61B increase.
  • UBS's biggest Q1 2014 reduction was Herc Holdings, cutting an estimated $419M.
  • UBS fully exited COLE REAL ESTATE INVESTMENTS, INC COM in Q1 2014, selling an estimated $233M.
  • UBS's ten largest holdings make up 14% of its $113B portfolio in Q1 2014.
  • UBS opened 1,144 new positions and closed 1,117 in Q1 2014.
  • UBS's portfolio value rose 5.2% quarter-over-quarter to $113B.

Based on UBS's 13F filing for Q1 2014, filed 15 May 2014.